Screener
Kyverna Therapeutics, Inc. KYTX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219397
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease right-of-use assets | 8,192 | 3,568 |
| Finance lease right-of-use assets | 198 | 305 |
| Other non-current assets | 5,014 | 4,903 |
| Total assets | $257,024 | $293,826 |
| Liabilities and stockholders’ equity | ||
| Current liabilities | ||
| Accounts payable | $11,603 | $5,306 |
| Accrued compensation | 3,114 | 9,990 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Kyverna Therapeutics, Inc.'s total assets?
- Kyverna Therapeutics, Inc. (KYTX) reported total assets of $257.02M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s total assets changed year-over-year?
- Kyverna Therapeutics, Inc.'s total assets decreased by 1.4% year-over-year, from $260.66M to $257.02M.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s total assets?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s total assets has grown at a 97.7% compound annual growth rate (CAGR), from $75.2M to $293.83M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Kyverna Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude